ArticleEuropean urology2023

Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial.

Ekaterina Laukhtina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.